Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil

S. J. Li, J. P. Wehrle, J. D. Glickson, N. Kumar, Paul G Braunschweiger

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Treatment of RIF-1 solid tumors with 5-fluorouracil (5-FU, 100 or 200 mg/kg, ip) caused substantial regression of the tumors, with regrowth initiated on Day 6 (100 mg/kg) or Day 9 (200 mg/kg). Blood perfusion in the tumor, estimated by uptake of 86Rb+, was significantly increased after treatment with 5-FU, while Rb+ uptake in normal tissues (skin, muscle) was unaffected. The increase in tumor perfusion during the first few days following treatment was significantly greater in animals treated with the higher dose of 5-FU. Perfusion-dependent 86Rb+ uptake returned to control levels by the 9th day after treatment with 100 mg/kg of 5-FU, but remained elevated on Days 9-12 after the higher dose. By the 1st day following treatment with 5-FU, in vivo 31P NMR spectra of treated tumors indicated significantly higher ratios of phosphocreatine to P(i), higher pH, and lower ratios of P(i) to nucleoside triphosphates compared to untreated age-matched controls. These changes persisted for 9 days following the lower 5-FU dose and for at least 12 days following the higher dose. Treatment with 5-FU induces profound, dose-dependent changes in tumor bioenergetics, which may result, at least in part, from changes in tumor perfusion after cytoreduction.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalMagnetic Resonance in Medicine
Volume22
Issue number1
DOIs
StatePublished - Dec 6 1991

Fingerprint

Fluorouracil
Energy Metabolism
Neoplasms
Perfusion
Phosphocreatine
Nucleosides
Muscles
Skin

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Li, S. J., Wehrle, J. P., Glickson, J. D., Kumar, N., & Braunschweiger, P. G. (1991). Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magnetic Resonance in Medicine, 22(1), 47-56. https://doi.org/10.1002/mrm.1910220106

Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. / Li, S. J.; Wehrle, J. P.; Glickson, J. D.; Kumar, N.; Braunschweiger, Paul G.

In: Magnetic Resonance in Medicine, Vol. 22, No. 1, 06.12.1991, p. 47-56.

Research output: Contribution to journalArticle

Li, SJ, Wehrle, JP, Glickson, JD, Kumar, N & Braunschweiger, PG 1991, 'Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil', Magnetic Resonance in Medicine, vol. 22, no. 1, pp. 47-56. https://doi.org/10.1002/mrm.1910220106
Li, S. J. ; Wehrle, J. P. ; Glickson, J. D. ; Kumar, N. ; Braunschweiger, Paul G. / Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. In: Magnetic Resonance in Medicine. 1991 ; Vol. 22, No. 1. pp. 47-56.
@article{0d74a95bce0d43bbb2720ae780f53579,
title = "Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil",
abstract = "Treatment of RIF-1 solid tumors with 5-fluorouracil (5-FU, 100 or 200 mg/kg, ip) caused substantial regression of the tumors, with regrowth initiated on Day 6 (100 mg/kg) or Day 9 (200 mg/kg). Blood perfusion in the tumor, estimated by uptake of 86Rb+, was significantly increased after treatment with 5-FU, while Rb+ uptake in normal tissues (skin, muscle) was unaffected. The increase in tumor perfusion during the first few days following treatment was significantly greater in animals treated with the higher dose of 5-FU. Perfusion-dependent 86Rb+ uptake returned to control levels by the 9th day after treatment with 100 mg/kg of 5-FU, but remained elevated on Days 9-12 after the higher dose. By the 1st day following treatment with 5-FU, in vivo 31P NMR spectra of treated tumors indicated significantly higher ratios of phosphocreatine to P(i), higher pH, and lower ratios of P(i) to nucleoside triphosphates compared to untreated age-matched controls. These changes persisted for 9 days following the lower 5-FU dose and for at least 12 days following the higher dose. Treatment with 5-FU induces profound, dose-dependent changes in tumor bioenergetics, which may result, at least in part, from changes in tumor perfusion after cytoreduction.",
author = "Li, {S. J.} and Wehrle, {J. P.} and Glickson, {J. D.} and N. Kumar and Braunschweiger, {Paul G}",
year = "1991",
month = "12",
day = "6",
doi = "10.1002/mrm.1910220106",
language = "English",
volume = "22",
pages = "47--56",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil

AU - Li, S. J.

AU - Wehrle, J. P.

AU - Glickson, J. D.

AU - Kumar, N.

AU - Braunschweiger, Paul G

PY - 1991/12/6

Y1 - 1991/12/6

N2 - Treatment of RIF-1 solid tumors with 5-fluorouracil (5-FU, 100 or 200 mg/kg, ip) caused substantial regression of the tumors, with regrowth initiated on Day 6 (100 mg/kg) or Day 9 (200 mg/kg). Blood perfusion in the tumor, estimated by uptake of 86Rb+, was significantly increased after treatment with 5-FU, while Rb+ uptake in normal tissues (skin, muscle) was unaffected. The increase in tumor perfusion during the first few days following treatment was significantly greater in animals treated with the higher dose of 5-FU. Perfusion-dependent 86Rb+ uptake returned to control levels by the 9th day after treatment with 100 mg/kg of 5-FU, but remained elevated on Days 9-12 after the higher dose. By the 1st day following treatment with 5-FU, in vivo 31P NMR spectra of treated tumors indicated significantly higher ratios of phosphocreatine to P(i), higher pH, and lower ratios of P(i) to nucleoside triphosphates compared to untreated age-matched controls. These changes persisted for 9 days following the lower 5-FU dose and for at least 12 days following the higher dose. Treatment with 5-FU induces profound, dose-dependent changes in tumor bioenergetics, which may result, at least in part, from changes in tumor perfusion after cytoreduction.

AB - Treatment of RIF-1 solid tumors with 5-fluorouracil (5-FU, 100 or 200 mg/kg, ip) caused substantial regression of the tumors, with regrowth initiated on Day 6 (100 mg/kg) or Day 9 (200 mg/kg). Blood perfusion in the tumor, estimated by uptake of 86Rb+, was significantly increased after treatment with 5-FU, while Rb+ uptake in normal tissues (skin, muscle) was unaffected. The increase in tumor perfusion during the first few days following treatment was significantly greater in animals treated with the higher dose of 5-FU. Perfusion-dependent 86Rb+ uptake returned to control levels by the 9th day after treatment with 100 mg/kg of 5-FU, but remained elevated on Days 9-12 after the higher dose. By the 1st day following treatment with 5-FU, in vivo 31P NMR spectra of treated tumors indicated significantly higher ratios of phosphocreatine to P(i), higher pH, and lower ratios of P(i) to nucleoside triphosphates compared to untreated age-matched controls. These changes persisted for 9 days following the lower 5-FU dose and for at least 12 days following the higher dose. Treatment with 5-FU induces profound, dose-dependent changes in tumor bioenergetics, which may result, at least in part, from changes in tumor perfusion after cytoreduction.

UR - http://www.scopus.com/inward/record.url?scp=0025833931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025833931&partnerID=8YFLogxK

U2 - 10.1002/mrm.1910220106

DO - 10.1002/mrm.1910220106

M3 - Article

VL - 22

SP - 47

EP - 56

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 1

ER -